We are pleased to announce that our clinic has moved to our new, fully-fledged healthcare facility, designed from the ground up to better serve our patients. As part of this move, we have renewed all of our equipment and upgraded our medical devices to the newest generation, enhancing both the safety and precision of the treatments we provide.

A major milestone in this transition is that our in-patient services, including hospitalisation and intensive care, are now provided at our clinic, rather than being outsourced from external centres. This allows us to offer more seamless, continuous care and closer coordination between our medical teams throughout each step of a patient’s journey.

With the new premises, we have also significantly expanded our range of therapies. Our Interventional Radiology service now includes advanced procedures such as Transarterial Chemoembolization (TACE), Radiofrequency (RF) and Microwave (MW) Ablation, and Chemosaturation, in addition to biopsy and catheter placement. We have introduced Theranostics services, including Lutetium-177 PSMA Therapy, Actinium-225 Therapy, Radioactive Iodine (RAI) Therapy, and Transarterial Radioembolization (TARE), supporting a more targeted and personalised approach to cancer care.

In addition, Radiation Oncology treatments that were previously performed in outside hospitals—such as IMRT, VMAT, SRS, SBRT, and IGRT—are now all available on-site at our clinic. Our Radiology & Nuclear Medicine capabilities have also been brought under one roof, including PET-CT, SPECT-CT, X-ray, CT, MRI, Ultrasound, Mammography, and Doppler Ultrasound, which were formerly done at external imaging centres.

We look forward to welcoming patients and their families to our new facility and to providing an even higher standard of integrated and innovative cancer care.